| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |